Skip to content

Prognostic Significance of the Baroreflex Sensitivity Changes After Acute Ischemic Stroke

Noninvasive Study of the Time Course of Baroreflex Sensitivity 6-Month After Acute Ischemic Stroke and the Relation of Its Changes With Post Stroke Prognosis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00422474
Enrollment
100
Registered
2007-01-17
Start date
2007-01-31
Completion date
Unknown
Last updated
2008-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autonomic Nervous System Diseases, Baroreflexes, Cerebrovascular Accident

Keywords

Ischemic stroke, Baroreflex sensitivity, Prognosis, Cardiovascular autonomic regulation

Brief summary

After acute stroke, baroreflex sensitivity (BRS) is impaired. This impaired acute stage BRS has been reported to be predictive of worsen outcome years after stroke in general. However, it is not very clear if the impaired acute stroke BRS would actually persist months after the acute stage. It is also not clear that such change, if any, would correlate with the functional outcome or prognosis after stroke. The trial is to investigate the longitudinal time course of BRS after ischemic stroke up to the 6th month post stroke and to see if there is any correlation of the changes in BRS with the functional outcome parameters using NIHSS and mRS scores throughout this period.

Interventions

None listed

Sponsors

Far Eastern Memorial Hospital
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Baroreflex sensitivity can be done within 72 hours of onset of acute ischemic stroke * 50-80 years old * Must have either brain CT or brain MRI done

Exclusion criteria

* NIHSS score \> 10 * Patient could not cooperate * Unstable vital sign * Atrial fibrillation * Transient ischemic attack patient * Diabetic patient * Impaired renal function (Cr \> 2.26 mg/dl) * Unstable angina, acute myocardiac infarction, cardiomyopathy patients * Patient who has known autonomic dysfunction

Countries

Taiwan

Contacts

Primary ContactSiupak Lee, M.D.
siupakmd@ms1.hinet.net

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026